The global buccal drug delivery systems market size is expected to reach USD 6.56 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to grow at a CAGR of 6.2% from 2024 to 2030. Buccal drug delivery systems have gained significant momentum since the last decade. Elimination of first-pass metabolism, quick absorption of the pH-sensitive drug, no interaction with stomach acid, quicker onset of action than any oral dose, minimal side effects, and reduced drug degradation are some of the factors fueling the market growth. Buccal drug delivery has gained large acceptance among geriatric patients and patients having difficulty swallowing.
Buccal Drug Delivery Systems Market Report Highlights
- The buccal tablets and lozenges type segment accounted for the largest revenue share in 2023 due to its wider acceptance among patients
- The smoking cessation application segment held the largest share in 2023. Buccal drug delivery is often the most preferred and effective formulation for treating patients with smoking or nicotine addiction
- The hospital end-user segment captured the largest revenue share in 2023 owing to a large number of admissions of geriatric patients and abundant medication supplies
- North America held the largest revenue share in 2023 due to a large number of leading manufacturers and growing research in the region
For More Details or Sample Copy please visit link @: Buccal Drug Delivery Systems Market Report
Leading players like Generex, NovaDel, Biodiversity Sciences International, and Transcept Pharmaceuticals are constantly developing critical drugs like insulin, heparin, morphine, long-lasting pain analgesics, and some anti cardiac drugs into rapid mists, mucoadhesive discs, and lozenges. Commercialization of this research would eventually lead to being a major life savior as it would ensure the faster onset of action and eliminate drug degradation. Despite the increased R&D activity among market players, asteep decline was observed in the sales and revenue gains due to the outbreak of the Covid-19 pandemic. Except for covid medications, several other drug markets were majorly hit leading to the dip in the market for buccal drug delivery. However, it is expected to bounce back by 2022.
List Of major companies in the Buccal Drug Delivery Systems Market
- GSK plc
- Teva Pharmaceutical Industries Ltd.
- Pfizer Inc.
- Generex Biotechnology Corporation (LUMITOS AG)
- ARx, LLC.
- Endo, Inc.
- Catalent, Inc
- Cynapsus Therapeutics Inc.
- Collegium Pharmaceutical
- Indivior PLC
For Customized reports or Special Pricing please visit @: Buccal Drug Delivery Systems Market Analysis Report
We have segmented the global buccal drug delivery systems market on the basis of type, application, end-user, and region.
Research Methodology
We employ a comprehensive and iterative research methodology focused on minimizing deviance in order to provide the most accurate estimates and forecasts possible. We utilize a combination of bottom-up and top-down approaches for segmenting and estimating quantitative aspects of the market. Data is continuously filtered to ensure that only validated and authenticated sources are considered. In addition, data is also mined from a host of reports in our repository, as well as a number of reputed paid databases. Our market estimates and forecasts are derived through simulation models. A unique model is created and customized for each study. Gathered information for market dynamics, technology landscape, application development, and pricing trends are fed into the model and analyzed simultaneously.
About Grand View Research
Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S. based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.
Contact:
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll-Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Web: https://www.grandviewresearch.com
#BuccalDrugDelivery #Pharmaceuticals #DrugDeliverySystems #BuccalTablets #OralMedication #BuccalRoute #HealthcareInnovation #MedicalTechnology #PharmaIndustry #DrugDeliveryInnovation #Bioavailability #PatientCare #PharmaceuticalResearch #MedicalDevices #DrugFormulation #Pharmacokinetics
